Additionally, based on the combination expression of LINC02774 and RP58, we demonstrated that glioma patients with high expression of both LINC02774 and RP58 tended to have longer survival, while patients with differential expression of the two genes had intermediate prognostic outcomes. Here, LINC02774 is linked to central nervous system cancer.